Видео ютуба по тегу Antibody Drugs

Targeting tumours: Challenges of antibody-drug conjugates
Targeting tumours: Challenges of antibody-drug conjugates
What are antibody-drug conjugates and how do they work against cancer?
What are antibody-drug conjugates and how do they work against cancer?
Therapeutic (Monoclonal) Antibodies
Therapeutic (Monoclonal) Antibodies
What are Antibody-drug Conjugates (ADCs)?
What are Antibody-drug Conjugates (ADCs)?
Sanofi – Antibody – Drug Conjugates
Sanofi – Antibody – Drug Conjugates
Understanding Antibody Drug Conjugates
Understanding Antibody Drug Conjugates
How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others
How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others
What are Antibody Drug Conjugates (ADCs)?
What are Antibody Drug Conjugates (ADCs)?
Advances in antibody-drug conjugates in oncogenic-addicted NSCLC
Advances in antibody-drug conjugates in oncogenic-addicted NSCLC
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference
Therapeutic antibodies (Part 3): antibody-drug conjugates
Therapeutic antibodies (Part 3): antibody-drug conjugates
Monoclonal antibodies in medicine
Monoclonal antibodies in medicine
What are antibody drug conjugates?
What are antibody drug conjugates?
Antibody drugs and blood plasma therapy: Livesavers for COVID patients? | COVID-19 Special
Antibody drugs and blood plasma therapy: Livesavers for COVID patients? | COVID-19 Special
Antibody Drug Conjugates: Characterization
Antibody Drug Conjugates: Characterization
DESTINY-CRC02: antibody-drug conjugates in colorectal cancer
DESTINY-CRC02: antibody-drug conjugates in colorectal cancer
WH defends FDA halting use of antibody drugs
WH defends FDA halting use of antibody drugs
Antibody Drug Discovery Against Difficult Targets
Antibody Drug Discovery Against Difficult Targets
New antibodies and antibody-drug conjugates for B-cell lymphoma
New antibodies and antibody-drug conjugates for B-cell lymphoma
Antibody drug development challenges & solutions
Antibody drug development challenges & solutions